Fig. 3

Survival curves of EOC patients with HCMV protein expression. a EOC patients who had focal or negative HCMV-IE expression in their tumors had significantly longer median OS than those with extensive HCMV-IE expression (41 vs.39 months, P = 0.03). b No significant difference in OS was observed in EOC patients with focal/negative or extensive HCMV-pp65 expression in their tumors (42 vs. 40 months, P = 0.37)